Nonprofit · EIN 52-1983273
FRIENDS OF CANCER RESEARCH
Tax-exempt · WASHINGTON, DC 20036
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $7,499,449 | $5,771,194 | $1,728,255 | $23,104,598 | $4,290,909 | $18,813,689 |
| December 31, 2023 | 990 | $7,186,730 | $5,245,007 | $1,941,723 | $19,663,708 | $3,827,913 | $15,835,795 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $6,949,510
- Program service revenue
- $0
- Investment income
- $549,939
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $1,636,845
- Other salaries and wages
- $1,122,473
- Salaries, compensation and benefits (total)
- $3,021,050
- Professional fundraising fees
- $0
- Legal fees
- $62,155
- Accounting fees
- $121,641
- Occupancy
- $382,528
- Travel
- $65,708
- Depreciation
- $69,416
- Program services (functional)
- $3,610,497
- Management and general (functional)
- $1,096,637
- Fundraising (functional)
- $1,064,060
Balance sheet and other
- Total assets, start of year
- $19,663,708
- Total assets, end of year
- $23,104,598
- Total liabilities, end of year
- $4,290,909
- Net assets, end of year
- $18,813,689
- Land, buildings and equipment
- $94,929
- Publicly traded securities
- $16,588,415
- Net assets without donor restrictions
- $17,036,189
- Net assets with donor restrictions
- $1,777,500
- Gross receipts
- $7,499,449
- Employees
- 16
- Volunteers
- 15
- Year formed
- 1996
- State of legal domicile
- DC
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| Jeff Allen PhD | President & CEO Trustee or director, Officer | 40 | $644,527 | $121,824 |
| Ryan Hohman JD | VP-Public Affairs | 40 | $299,686 | $23,972 |
| Mark Stewart PhD | VP-Science Policy | 40 | $286,475 | $21,465 |
| Heather Chaney | VP-Operations | 40 | $214,521 | $24,481 |
| Hillary Andrews | Dir.-Reg & Res Par | 40 | $179,111 | $24,224 |
| linda ostermann | Dir.-Grant & Oper | 40 | $154,088 | $21,809 |
| Brittany McKelvey | Dir.-Reg Affairs | 40 | $142,236 | $6,637 |
| Finnian Galloway-Kane | Dir-Pub Relations | 40 | $113,418 | $14,378 |
| Pennie Abramson PhD | Director Trustee or director | 0.5 | $0 | $0 |
| Carolyn Aldige | Director Trustee or director | 0.5 | $0 | $0 |
| Anna D Barker PhD | Secretary Trustee or director, Officer | 0.5 | $0 | $0 |
| Edward Sanghyun Kim MD MBA | Director Trustee or director | 0.5 | $0 | $0 |
| Roy Herbst MD PhD | Director Trustee or director | 0.5 | $0 | $0 |
| Ellen Sigal PhD | Chair & Founder Trustee or director, Officer | 0.5 | $0 | $0 |
| Marlene Malek RN | Vice Chair Trustee or director, Officer | 0.5 | $0 | $0 |
7 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Sudip Parikh PhD | Treasurer Trustee or director, Officer | 0.5 | $0 |
| Margaret Foti PhD MD | Executive Dir. Trustee or director | 0.5 | $0 |
| David Mitchell | Executive Dir. Trustee or director | 0.5 | $0 |
| Richard Schilsky MD | Executive Dir. Trustee or director | 0.5 | $0 |
| Elizabeth Thompson | Director Trustee or director | 0.5 | $0 |
| Edward J Benz Jr MD | Director Trustee or director | 0.5 | $0 |
| Margaret Anderson | Director Trustee or director | 0.5 | $0 |
990 for the year ended December 31, 2023: 21 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| Jeff Allen PhD | President & CEO Trustee or director, Officer | 40 | $622,957 | $115,666 |
| Ryan Hohman JD | VP-Public Affairs | 40 | $285,934 | $20,833 |
| Mark Stewart PhD | VP-Science Policy | 40 | $258,113 | $16,275 |
| Heather Chaney | VP-Operations | 40 | $207,967 | $20,012 |
| Hillary Andrews | Dir.-Reg & Res Par | 40 | $161,668 | $16,303 |
| linda ostermann | Dir.-Grant & Oper | 40 | $150,093 | $14,773 |
| Brittany McKelvey | Dir.-Reg Affairs | 40 | $132,947 | $5,623 |
| Pennie Abramson PhD | Director Trustee or director | 0.5 | $0 | $0 |
| Carolyn Aldige | Director Trustee or director | 0.5 | $0 | $0 |
| Anna D Barker PhD | Exec. Committee Trustee or director, Officer | 0.5 | $0 | $0 |
| Edward Sanghyun Kim MD MBA | Director Trustee or director | 0.5 | $0 | $0 |
| Roy Herbst MD PhD | Director Trustee or director | 0.5 | $0 | $0 |
| Ellen Sigal PhD | Chair & Founder Trustee or director, Officer | 0.5 | $0 | $0 |
| Marlene Malek RN | Vice Chair Trustee or director, Officer | 0.5 | $0 | $0 |
| Sudip Parikh PhD | Exec. Committee Trustee or director, Officer | 0.5 | $0 | $0 |
| Margaret Foti PhD MD | Exec. Committee Trustee or director, Officer | 0.5 | $0 | $0 |
| David Mitchell | Exec. Committee Trustee or director, Officer | 0.5 | $0 | $0 |
| Richard Schilsky MD | Exec. Committee Trustee or director, Officer | 0.5 | $0 | $0 |
| Elizabeth Thompson | Director Trustee or director | 0.5 | $0 | $0 |
| Edward J Benz Jr MD | Director Trustee or director | 0.5 | $0 | $0 |
| Margaret Anderson | Director Trustee or director | 0.5 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 1800 M ST NW SUITE 1050S, WASHINGTON, DC 20036-5802
- In care of
- % ELLEN SIGAL
- Principal officer (990 for 2024)
- Jeff Allen PhD, 1800 M Street NW 1050S, Washington, DC 20036
- Signed the 990
- Jeff Allen PhD, President & CEO
- Phone
- (202) 944-6700
- Website
- WWW.FOCR.ORG
- Return prepared by
- Lydon Fetterolf Corydon PA
Mission
TO DRIVE COLLABORATION AMONG PARTNERS FROM EVERY HEALTHCARE SECTOR TO POWER ADVANCES IN SCIENCE, POLICY AND REGULATION THAT SPEED LIFE-SAVING TREATMENTS TO PATIENTS.
Program accomplishments
- Science Policy: Friends of Cancer Research drives collaboration among partners from every healthcare sector to power advances in science, policy and regulation that speed life-saving treatments to patients. Master Protocols present opportunities to improve clinical trial efficiencies and more accessible for patients. This includes the Lung-MAP study, a unique, collaborative cancer clinical trial that uses genetic screening to match patients to investigational new treatments for non-small cell lung cancers.Expenses $2,442,055
- Communication: THE Organization PROVIDES INDEPTH COVERAGE OF THE EVENTS, TRENDS, AND ISSUES THAT AFFECT the public healthcare INDUSTRY.Expenses $545,160
- Meetings and Professional Development: Friends of Cancer Research brings together leaders in cancer drug development, federal health and regulatory agencies, academic research, the private sector, and patient advocates for focused discussions on key issues surrounding the development and regulation of cancer drugs and therapies.Expenses $510,658
- Patient Advocacy Training: Patient advocacy encompasses engaging, educating and empowering patients through ProgressforPatients.org and Project TEACH which empowers Black women through education and outreach to participate in and effectively engage with researchers and clinicians.Expenses $112,624
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 52-1983273
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1996
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H30)
- Assets (IRS master file)
- $23,104,598
- Income (IRS master file)
- $7,499,449
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $7,499,449 | $5,771,194 | $23,104,598 | IRS |
| 990-T | December 2024 | – | – | – | IRS |
| 990 | December 2023 | $7,186,730 | $5,245,007 | $19,663,708 | XML |
| 990-T | December 2023 | – | – | – | IRS |
| 990 | December 2022 | $6,784,533 | $4,975,120 | $13,380,551 | IRS |
| 990-T | December 2022 | – | – | – | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990-T | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990 | December 2017 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 52-1983273).
Questions about FRIENDS OF CANCER RESEARCH
- What is the EIN of FRIENDS OF CANCER RESEARCH?
- The employer identification number (EIN) of FRIENDS OF CANCER RESEARCH is 52-1983273.
- Is FRIENDS OF CANCER RESEARCH tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1996.
- Are donations to FRIENDS OF CANCER RESEARCH tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does FRIENDS OF CANCER RESEARCH file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of FRIENDS OF CANCER RESEARCH due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did FRIENDS OF CANCER RESEARCH last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of FRIENDS OF CANCER RESEARCH?
- The 990 for the year ended December 31, 2024 names Jeff Allen PhD.
- Who are the officers and directors of FRIENDS OF CANCER RESEARCH?
- The 990 for the year ended December 31, 2024 lists 22 people; 8 received compensation from the organization, the highest $644,527 (Jeff Allen PhD, President & CEO).
- How much revenue does FRIENDS OF CANCER RESEARCH have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $7,499,449, expenses of $5,771,194 and total assets of $23,104,598 at year end.
Other nonprofits in WASHINGTON
- ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION EIN 95-4191698 · last filed 990 for 2024
- CHILDRENS RESEARCH INSTITUTE EIN 52-1654453 · last filed 990 for 2025
- PARALYZED VETERANS OF AMERICA EIN 13-1946868 · last filed 990 for 2025
- SOCIETY FOR NEUROSCIENCE EIN 52-0895843 · last filed 990 for 2025
- USAGAINSTALZHEIMERS EIN 45-0672514 · last filed 990 for 2025
- ALLIANCE FOR REGENERATIVE MEDICINE EIN 27-0486705 · last filed 990 for 2025
- AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC EIN 52-2340031 · last filed 990 for 2025
- AMERICAN JOURNAL OF PREVENTIVE MEDICINE EIN 52-1385415 · last filed 990 for 2024
All nonprofits in WASHINGTON · District of Columbia · Medical research